Argatroban Impurity 9

Basic Information

View in Editor

CAS Number

153886-69-2

Molecular Formula

C10H9NO3S

Molecular Weight

223.25 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Basic Physical Properties

SMILES

View in Editor

Cc1cc2cccc(c2nc1)S(=O)(=O)O

InChI

InChI=1S/C10H9NO3S/c1-7-5-8-3-2-4-9(15(12,13)14)10(8)11-6-7/h2-6H,1H3,(H,12,13,14)

InChIKey

BTBNYOKJERLLQI-UHFFFAOYSA-N

LogP

1.7899200000000002

Topological Polar Surface Area

67.26 Å²

Hydrogen Bond Donor/Acceptor

1 / 4

Synonyms & References

English

3-Methyl-8-quinolinesulfonic Acid
3-Methyl-8-quinoline
3-methylquinoline-8-sulfonic acid
3-methylquinoline-8-sulphonic acid
Argatroban Impurity 30
3-Methyl-8-Quinolinesulfonic Acid(WX682203)

MDL Number

MFCD07369543

FAQ

What regulatory guidelines apply to Argatroban Impurity 9 (CAS: 153886-69-2)?

Argatroban Impurity 9 (CAS: 153886-69-2) must comply with chemical regulations such as REACH in the European Union, which requires registration, evaluation, authorization, and restriction of chemical substances. It also falls under the purview of the EPA in the U.S. for environmental and safety standards. Additionally, the FDA may regulate it under drug manufacturing and safety guidelines.

Are there alternatives to Argatroban Impurity 9 in synthesis?

Alternatives to Argatroban Impurity 9 in synthesis include the use of isomers and analogs like nitrobenzene or similar compounds. Common reagents that could be used as substitutes include acetic anhydride and other derivatives of argatroban. These alternatives may offer similar functionalities or can be more readily available and less costly.

What is the market or research trend for Argatroban Impurity 9?

The market for Argatroban Impurity 9 (CAS: 153886-69-2) is primarily driven by pharmaceutical research and development, particularly in anticoagulant therapy. Research trends focus on its use in clinical trials for treating thrombotic disorders. The market is expected to grow due to increasing demand for safe and effective anticoagulant drugs.

How should waste containing Argatroban Impurity 9 be handled?

Waste containing Argatroban Impurity 9 (CAS: 153886-69-2) should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration is a common method for disposing of hazardous waste. Environmental protection measures include ensuring that waste is not released directly into water bodies or air, and following local and international environmental regulations.